Previously, Zhuang et al. showed that exosomes derived from mesenchymal stem cells pretreated with macrophage migration inhibitory factor (MIF) (exosomeMIF) have a therapeutic effect against the chemotherapy drug doxorubicin (DOX)-induced cardiomyopathy [73]. This evidence concerns the gene MIF and cardiomyopathy.